Salud financiera de hoja de balance de Groupe Bruxelles Lambert

Salud financiera controles de criterios 2/6

Groupe Bruxelles Lambert tiene un patrimonio de accionistas total de €16.2B y una deuda total de €8.3B, lo que sitúa su ratio deuda-patrimonio en 50.9%. Sus activos y pasivos totales son €27.7B y €11.5B respectivamente. El BAIT de Groupe Bruxelles Lambert es de €782.8M, por lo que su ratio de cobertura de intereses es de 2.9. Tiene efectivo e inversiones a corto plazo que ascienden a €2.9B.

Información clave

50.9%

Ratio deuda-patrimonio

€8.27b

Deuda

Ratio de cobertura de intereses	2.9x
Efectivo	€2.91b
Patrimonio	€16.24b
Total pasivo	€11.51b
Activos totales	€27.75b

Actualizaciones recientes sobre salud financiera

No hay actualizaciones

Recent updates

Pinning Down Groupe Bruxelles Lambert SA's (EBR:GBLB) P/E Is Difficult Right Now

Nov 04

Is Now The Time To Put Groupe Bruxelles Lambert (EBR:GBLB) On Your Watchlist?

Sep 30

Subdued Growth No Barrier To Groupe Bruxelles Lambert SA's (EBR:GBLB) Price

Jun 08

Investors Appear Satisfied With Groupe Bruxelles Lambert SA's (EBR:GBLB) Prospects

Dec 18

Análisis de la situación financiera

Pasivos a corto plazo: Los activos a corto plazo (€5.3B) de GBLB superan a sus pasivos a corto plazo (€2.8B).

Pasivo a largo plazo: Los activos a corto plazo (€5.3B) de GBLB no cubren sus pasivos a largo plazo (€8.7B).

Historial y análisis de deuda-patrimonio

Nivel de deuda: El ratio deuda neta-patrimonio (33%) de GBLB se considera satisfactorio.

Reducción de la deuda: El ratio deuda-patrimonio de GBLB ha crecido de 25.7% a 50.9% en los últimos 5 años.

Cobertura de la deuda: La deuda de GBLB no está bien cubierta por el flujo de caja operativo (10.2%).

Cobertura de intereses: Los pagos de intereses de la deuda de GBLB no están bien cubiertos por el BAIT (2.9x cobertura).

Salud financiera de hoja de balance de Groupe Bruxelles Lambert

Salud financiera controles de criterios 2/6

Información clave

Actualizaciones recientes sobre salud financiera

Recent updates

Third quarter 2024 earnings released: €1.61 loss per share (vs €0.35 profit in 3Q 2023)

Groupe Bruxelles Lambert SA to Report Nine Months, 2025 Results on Nov 06, 2025

Groupe Bruxelles Lambert SA to Report First Half, 2025 Results on Jul 31, 2025

Pinning Down Groupe Bruxelles Lambert SA's (EBR:GBLB) P/E Is Difficult Right Now

PE Firms Reportedly to Circle German Vitamin Supplement Maker Orthomol

Is Now The Time To Put Groupe Bruxelles Lambert (EBR:GBLB) On Your Watchlist?

Groupe Bruxelles Lambert SA to Report Fiscal Year 2024 Results on Mar 13, 2025

Second quarter 2024 earnings released: EPS: €0.67 (vs €1.53 in 2Q 2023)

Subdued Growth No Barrier To Groupe Bruxelles Lambert SA's (EBR:GBLB) Price

New major risk - Revenue and earnings growth

First quarter 2024 earnings released: EPS: €1.43 (vs €0.74 in 1Q 2023)

Upcoming dividend of €1.93 per share

New major risk - Revenue and earnings growth

Groupe Bruxelles Lambert SA to Report Q3, 2024 Results on Nov 07, 2024

Investors Appear Satisfied With Groupe Bruxelles Lambert SA's (EBR:GBLB) Prospects

Groupe Bruxelles Lambert SA to Report Q2, 2024 Results on Jul 31, 2024

Concentrix Corporation (NasdaqGS:CNXC) completed the acquisition of Webhelp SAS from Groupe Bruxelles Lambert SA (ENXTBR:GBLB), Marnix Luxembourg S.à R.l. and management of Webhelp.

Groupe Bruxelles Lambert SA to Report First Half, 2023 Results on Jul 31, 2023

Groupe Bruxelles Lambert SA to Report First Half, 2023 Results on Jul 31, 2023

Upcoming dividend of €1.93 per share at 3.5% yield

Full year 2022 earnings released

Price target decreased to €97.00

Third quarter 2022 earnings released

Second quarter 2022 earnings released: €1.38 loss per share (vs €0.72 profit in 2Q 2021)

First quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Upcoming dividend of €1.93 per share

Groupe Bruxelles Lambert SA (ENXTBR:GBLB) signed an agreement to acquire an unknown majority stake in Sanoptis AG from Telemos Capital Limited.

Groupe Bruxelles Lambert SA (ENXTBR:GBLB) along with the management of Affidea has signed a definitive agreement to acquire a majority stake in Affidea B.V. from B-FLEXION Group for approximately €1 billion.

Gbl Reportedly Set to Buy Affidea

Full year 2021 earnings: EPS and revenues miss analyst expectations

Groupe Bruxelles Lambert Reportedly Considering A Bid to Take Ontex Group Private

Third quarter 2021 earnings released: €0.29 loss per share (vs €0.40 loss in 3Q 2020)

Second quarter 2021 earnings released: EPS €0.72 (vs €2.49 in 2Q 2020)

Here's Why We Think Groupe Bruxelles Lambert (EBR:GBLB) Is Well Worth Watching

Upcoming dividend of €1.75 per share

Consensus forecasts updated

Full year 2020 earnings released: EPS €2.53 (vs €4.49 in FY 2019)

Price target increased to €95.11

Did You Miss Groupe Bruxelles Lambert's (EBR:GBLB) 44% Share Price Gain?

New 90-day high: €86.02

Is Groupe Bruxelles Lambert SA (EBR:GBLB) A Risky Dividend Stock?

How Much Of Groupe Bruxelles Lambert SA (EBR:GBLB) Do Institutions Own?

Groupe Bruxelles Lambert SA, Annual General Meeting, Apr 27, 2021

New 90-day high: €83.74

New 90-day high: €83.00

Groupe Bruxelles Lambert SA (ENXTBR:GBLB), Future Shape LLC and Roman Arnold signed a definitive agreement to acquire Canyon Bicycles GmbH from TSG Consumer Partners, LP, Roman Arnold and others.

A Look At Groupe Bruxelles Lambert's (EBR:GBLB) CEO Remuneration

Analysts lower EPS estimates to €2.69

Third quarter 2020 earnings released: €0.40 loss per share

New 90-day low: €73.26

New 90-day high - €79.90

Groupe Bruxelles Lambert SA (ENXTBR:GBLB) completed the acquisition of 60% stake in Webhelp SAS from KKR & Co. Inc. (NYSE:KKR), Frédéric Jousset, Olivier Duha and others.

Análisis de la situación financiera

Historial y análisis de deuda-patrimonio

Hoja de balance

Descubre empresas con salud financiera